JPRN-UMIN000006725Recruiting未知
Prospective study for the expression of KL-6 and CEA in pancreato-billiary cancer - Prospective study for the expression of KL-6 and CEA in pancreato-billiary cancer
Department of Gastroenterology, Tottori University School of medicine0 sites120 target enrollmentStarted: November 15, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to 110years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Not Applicable
A prospective observational preliminary study of Korean medicine treatment for patients with fibromyalgiaKCT0007457Kyung Hee University Oriental Medical Center20
Recruiting
Not Applicable
A prospective observational preliminary study on Korean medicine treatment for patients with postherpetic neuralgiaDiseases of the nervous systemKCT0007458Kyung Hee University Oriental Medical Center20
Recruiting
Not Applicable
Prospective study on the usefulness of K-2S plus as as enteral nutrients after pancreatoduodenectomyPatients who undergo pancreatoduodenectomy for peri-pancreatic tumors such as pancreatic cancers or lower bile duct cancersJPRN-UMIN000036511Kumamoto University40
Active, not recruiting
Phase 1
Clinical Trial of MK-7684A with chemotherapy for extensive stage small cell lung cancer (ES-SCLC)Extensive-stage small-cell lung cancerMedDRA version: 21.1Level: PTClassification code 10041068Term: Small cell lung cancer extensive stageSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-005034-42-DEMerck Sharp & Dohme LLC450
Active, not recruiting
Phase 3
Phase 3 Study of Chemotherapy with MK-7684A or Atezolizumab in First-Line ES-SCLCES-SCLCJPRN-jRCT2021220008Ishii Takeaki30